2019-11-14T10:30:55-06:00 2018-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2018-01-01 131924236 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 YORK AVENUE NEW YORK NY 100656007 MARK K SVENNINGSON SVP FINANCE 6462273092 2019-11-14 true JENNIFER D RHODERICK P00395735 3176817000 108.206.163.59 35057220193185000005 2019-11-14 P 0AFC68C4871D6435D8AE6773914B3518CBCECFD3 770194AAF055F9EA87E64CA02E08FE540289067F 2018 2020-04-17 16:48:07Z CRAIG THOMPSON MD 1275 YORK AVENUE NEW YORK NY 100656007 1308540000 false X WWW.MSKCC.ORG X 1960 NY LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION 31 29 21014 960 -7881828 0 34535000 169497434 627812000 679144000 133406556 191805000 27963865 27298566 823717421 1067745000 1000000 1000000 0 0 416760965 452355050 128216 0 69396458 379562734 405217950 797451915 858573000 26265506 209172000 5568914000 5241684000 3541164000 3164525000 2027750000 2077159000 X MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. false false 715528368 672145000 MEMORIAL SLOAN-KETTERING CANCER CENTER PROVIDES THE FOLLOWING SERVICES TO ITS AFFILIATED ORGANIZATIONS: FINANCIAL ADMINISTRATION, EXECUTIVE MANAGEMENT, HUMAN RESOURCES, FACILITY MANAGEMENT, GENERAL AND ENVIRONMENTAL SERVICES, PROCUREMENT, PUBLIC AFFAIRS, RESEARCH TECHNOLOGY MANAGEMENT, CORPORATE COMPLIANCE, INFORMATION SYSTEMS AND TECHNOLOGY, AND INVESTMENT MANAGEMENT. IN ADDITION, CERTAIN SERVICES ARE PROVIDED ON A REQUISITION BASIS INCLUDING FOOD AND DIETARY SERVICES, FACILITIES MANAGEMENT (LOCKSMITH, ELECTRICIAN, PLUMBING, PAINTING AND CARPENTRY, ETC.) MEDICAL LIBRARY, CONFERENCE PLANNING, OCCUPANCY OF LEASED SPACE, TRANSPORTATION, IMMIGRATION SERVICES, MEDICAL ILLUSTRATION, MOTION MEDIA, SECURITY SERVICES SUCH AS INSTALLING ANTITHEFT DEVICES AND MAILROOM SERVICES. 5645080 MSKCC PAYS FEES TO CORNELL MEDICAL CENTER AND OTHER MEDICAL INSTITUTIONS FOR STAFF TO FURTHER THEIR SCIENTIFIC EDUCATION. IN ADDITION, THE CENTER HOSTS A NUMBER OF SYMPOSIUMS, SOME OF WHICH ARE OPEN TO THE PUBLIC. 22663282 1000000 18921000 CAFETERIA: THE CENTER OPERATES A CAFETERIA IN THE MAIN BUILDING COMPLEX WHERE VISITORS AND PATIENTS CAN PURCHASE MEALS AND SNACKS. SOCIETY OF MSKCC: THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER, FOUNDED IN 1946, IS A VOLUNTEER ORGANIZATION DEDICATED TO PROMOTING THE WELL-BEING OF PATIENTS, SUPPORTING CANCER RESEARCH AND PROVIDING PUBLIC EDUCATION ON THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER. THE COSTS SHOWN HERE ARE EXCLUSIVE OF FUNDRAISING ACTIVITIES, WHICH ARE REPORTED IN PART IX, COLUMN D. EXPENSE REVENUE CAFETERIA EXPENSE $ 9,378,404 $ 6,999,000 SOCIETY EXPENSE $ 3,836,973 $ 0 GRANTS TO RLC $ 1,000,000 $ 0 PCCTC $ 8,447,905 $11,922,000 TOTALS $22,663,282 $18,921,000 743836730 true true false true false false false false false true true true false false true false false true false false true false false false true false false true false true true false false false false false false false false false true true false false false true true true true false false true 1491 0 true 21014 true true true false false false false true true false false false false true false X 31 29 true false false false false false false true true false false false true true true true true true true true true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY X X MARK K SVENNINGSON 6462273414 633 THIRD AVENUE New York NY 10017 RICHARD I BEATTIE BOARD MEMBER 1.0 0.0 X 0 0 0 IAN COOK BOARD MEMBER 2.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER BOARD MEMBER 1.0 0.0 X 0 0 0 ANTHONY B EVNIN BOARD MEMBER 1.0 0.0 X 0 0 0 ROGER W FERGUSON BOARD MEMBER 1.0 0.0 X 0 0 0 WILLIAM E FORD BOARD MEMBER 1.0 0.0 X 0 0 0 RICHARD N FOSTER BOARD MEMBER 1.0 0.0 X 0 0 0 STEPHEN FRIEDMAN BOARD MEMBER 1.0 0.0 X 0 0 0 ELLEN V FUTTER BOARD MEMBER 1.0 0.0 X 0 0 0 LOUIS V GERSTNER JR BOARD MEMBER 1.0 0.0 X 0 0 0 JONATHAN N GRAYER BOARD MEMBER 1.0 0.0 X 0 0 0 JAMIE GREGORY BOARD MEMBER 1.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR BOARD MEMBER 1.0 0.0 X 0 0 0 DAVID H KOCH BOARD MEMBER 1.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS VICE CHAIR OF THE BOARD 2.0 0.0 X 0 0 0 JAMIE C NICHOLLS VICE CHAIR OF THE BOARD 2.0 0.0 X 0 0 0 JAMES G NIVEN BOARD MEMBER 1.0 0.0 X 0 0 0 BRUCE C RATNER BOARD MEMBER 1.0 0.0 X 0 0 0 ALEXANDER T ROBERTSON BOARD MEMBER 1.0 0.0 X 0 0 0 JAMES D ROBINSON III BD MEMBER & HONORARY CHAIRMAN 2.0 0.0 X 0 0 0 VIRGINIA M ROMETTY BOARD MEMBER 0.0 0.0 X 0 0 0 STEPHEN C SHERRILL BOARD MEMBER 1.0 0.0 X 0 0 0 PETER J SOLOMON BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN R STRANGFELD BOARD MEMBER 1.0 0.0 X 0 0 0 PETER A WEINBERG BOARD MEMBER 1.0 0.0 X 0 0 0 DEBORAH C WRIGHT BOARD MEMBER 1.0 0.0 X 0 0 0 SCOTT M STUART CHAIR-ELECT OF THE BOARD 2.0 0.0 X 0 0 0 CLIFTON S ROBBINS BOARD MEMBER & TREASURER 1.0 0.0 X X 0 0 0 NORMAN C SELBY BOARD MEMBER & SECRETARY 2.0 0.0 X X 0 0 0 CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 50.0 0.0 X X 2185786 0 1240566 DOUGLAS A WARNER III CHAIRMAN UNTIL 12/2018 2.0 0.0 X X 0 0 0 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 718302 0 75910 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 50.0 0.0 X 678172 0 77530 MICHAEL P GUTNICK EVP & CFO 50.0 0.0 X 1059967 0 70267 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 50.0 0.0 X 1583444 0 1018320 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 406458 0 60467 JORGE LOPEZ ESQ EVP & GENERAL COUNCEL 50.0 0.0 X 963244 0 73767 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 50.0 0.0 X 751074 0 70639 KATHRYN MARTIN COO 50.0 0.0 X 1375127 0 586105 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 50.0 0.0 X 445845 0 61396 RICHARD K NAUM SVP DEVELOPMENT RETIRED 7/1/18 50.0 0.0 X 229155 0 11899 PATRICIA C SKARULIS SVP & CHIEF INFO OFFICER 50.0 0.0 X 705910 0 55934 MARK SVENNINGSON SVP FINANCE, CONTROLLER 50.0 0.0 X 679765 0 76620 DEBRA BERNS ESQ SVP & SR RISK OFFICER 50.0 0.0 X 514225 0 38436 KENNETH MANOTTI VP DEVELOPMENT 50.0 0.0 X 570442 0 51462 WENDY PERCHICK SVP STRATEGIC PLANNING & INNOV 50.0 0.0 X 663894 0 64521 GREGORY RASKIN VP, TECHNOLOGY DEVELOPMENT 50.0 0.0 X 866703 0 68041 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 50.0 0.0 X 551247 0 62861 WILLIAM MORGAN VP HR SYSTEMS & OPERATIONS 50.0 0.0 X 832632 0 66468 TOMYA WATT VP TALENT ACQUISITION 50.0 0.0 X 617948 0 59490 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 0.0 0.0 X 121539 0 9635 16520879 0 3900334 1159 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCTION 259211227 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCTION 75715154 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCTION 19253167 LEND LEASE US CONSTRUCTION 200 PARK AVENUE NEW YORK NY 10166 GENERAL CONSTRUCTION 16718877 FIDELUS TECHNOLOGIES 240 W 35TH STREET NEW YORK NY 10001 IT CONSULTANTS 9449691 233 X 3832434 165665000 3114965 169497434 SERVICES PROVIDED SEE NOTE A & ATTACH.1 IN SCH O 900099 672145000 672145000 CAFETERIA 721000 6999000 6999000 679144000 84756000 -7881828 92637828 2166000 2166000 3858000 3858000 0 0 0 344554000 239671000 104883000 104883000 104883000 945536 3832434 1124000 -178464 -178464 0 0 0 0 0 0 RESEARCH EXPENSE RECOVERY 711110 11922000 11922000 GIFT SHOP INCOME 811000 592000 592000 VENDOR DISCOUNT 900099 975000 975000 10130030 10130030 23619030 1067745000 691066000 -7881828 215063394 1000000 1000000 0 0 0 16436237 12072011 3413876 950350 131174 120352 10822 332346477 302588103 5019809 24738565 27215880 25107835 322731 1785314 52952732 46510975 1578427 4863330 23272550 21655507 278355 1338688 0 13224358 12444019 614386 165953 1157356 1000439 155650 1267 872735 872735 0 5835331 5835331 44904082 33898295 1939785 9066002 24379973 19905849 4474124 120675214 95239389 8840408 16595417 40668014 39693958 232784 741272 1834895 1834895 39303915 38477462 607943 218510 2308341 1701151 129484 477706 0 4780222 4116511 6179 657532 9790809 9790809 0 60049983 55548701 3283987 1217295 2295511 2086977 76519 132015 NET REQUISITIONED SERVICES 25104115 20860296 1146701 3097118 FUNDRAISING EVENTS -1124000 -1124000 UBIT EXPENSE 219559 219559 PHARMACEUTICALS 488260 488260 8449277 8447905 1372 858573000 743836730 45339812 69396458 X 15357988 7058594 8299394 7267000 5479000 847162000 548854000 112707000 123112000 860060000 1005883000 0 0 0 0 36387000 38362000 520000 624000 99609000 95865000 942072000 572682000 316924000 369390000 2625175000 2506590000 642192000 547525000 20911000 0 0 0 0 0 5568914000 5241684000 354494000 423085000 0 0 0 0 1439048000 1051371000 0 0 0 0 0 0 1350000000 1350000000 397622000 340069000 3541164000 3164525000 X 1703809000 1771943000 131348000 97779000 192593000 207437000 2027750000 2077159000 5568914000 5241684000 X 209172000 -217639000 57876000 X false true X true X 67704247 51108585 67090737 34535000 169497434 389936003 0 0 67704247 51108585 67090737 34535000 169497434 389936003 99244439 290691564 21521254 63076697 26432410 47403556 90780000 249213917 0 0 639149920 2979165308 0.45481 0.52756 X PART I, LINE 3 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT MEMORIAL SLOAN-KETTERING CANCER CENTER QUALIFIES AS A PUBLIC CHARITY UNDER SECTION 170 (B) (1) (A) (iii). HOWEVER, SINCE IT DOES NOT OPERATE A HOSPITAL, IT IS NOT REQUIRED TO COMPLETE SCHEDULE H. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 872735 872735 872735 872735 857700265 4658697376 858573000 4659570111 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 733578 896016 793599 872735 3295928 250000 250000 250000 250000 1000000 1500000 PART II-A ALL LOBBYING ACTIVITIES ARE PERFORMED BY MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236). LOBBYING EXPENDITURES ARE EXPENSED BY THE CENTER AND ARE REPORTED ON THE STATEMENT OF FUNCTIONAL EXPENSE LINE 11d. THE CENTER HAS MADE THE 501(h) ELECTION. OUR AFFILIATED ORGANIZATIONS ARE IDENTIFIED BELOW. ALL AFFILIATES USE THE CORPORATE ADDRESS 1275 YORK AVENUE, NEW YORK, N.Y. 10065-6007. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (13-1624182), SKI REALTY, INC. (13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL (20-2212588), MSK. INSURANCE U.S., INC. (83-0363317), AND MSKCC PROTON INC., (35-2397819). 250120000 139261000 -3759000 385622000 217145357 20320000 12654643 250120000 211696215 13020 5436122 217145357 213471000 19530 -1794315 211696215 205654000 69000 7748000 213471000 0.46200 0.53800 false false 310443000 80350000 230093000 21878000 16974000 4904000 609751000 475358000 134393000 369390000 PRIVATE EQUITY & VENTURE CAP 550138000 F 550138000 0 PENSION AND POSTRETIREMENT 193416000 DEFERRED GIFT ANNUITY 17268000 ASSET RETIREMENT OBLIGATION 3272000 INSURANCE RESERVES 4167000 CAPTIVE INSURANCE LOAN AGREEME 121799000 ACCRUED SICK PAY 147000 340069000 836966000 -217639000 1124000 -216515000 1053481000 14264000 14264000 1067745000 844433000 1124000 1124000 843309000 14264000 1000000 15264000 858573000 INTENDED USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. OTHER RECONCILING ITEMS lines 2d DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS ARE REMOVED FROM THE FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE $1,124,000. OTHER RECONCILING ITEMS line 4b GRANT PAYMENTS TO RALPH LAUREN CENTER RECORDED BY MSK AS NON OPERATING EXPENSES TOTAL $1,000,000. East Asia and the Pacific Program Services INVESTMENT MEETINGS 73168 Central America and the Caribbean Program Services INVESTMENT MEETINGS 772 Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 71879 Middle East and North Africa Program Services INVESTMENT MEETINGS 1093 North America Program Services INVESTMENT MEETINGS 17294 South Asia Program Services INVESTMENT MEETINGS 23426 Central America and the Caribbean Investments 1650067000 Europe (Including Iceland and Greenland) Investments 40944000 Sub-Saharan Africa Investments 8272000 1699470632 1699470632 true false true true true false Organization's Procedures for Monitoring Use of Grant Funds Outside the US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE THE UNITED STATES. SCHEDULE F, PART I , LINE 3, COLUMN f VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. DONOR SERVICES TELEMARKET false AL AK AZ AR CA CO CT DE DC FL GA GU HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX VI UT VT VA WA WV WI WY SPRING BALL 1418937 980224 438713 110486 10539 122442 SPECIAL PROJ. 914800 872680 42120 73718 28639 5 2444233 1979530 464703 405123 50737 66650 255666 4777970 3832434 945536 478841 161223 77189 406747 1124000 -178464 true RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVENUE NEW YORK NY 10035 020597827 501(C)(3) 1000000 SUPPORT OPERATIONS 1 0 Form 990, Schedule I RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION. DURING 2018, MSKCC PAID $1,000,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION (RLC) TO OFFSET OPERATING EXPENSES. THE BOARD HAD APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER UP TO $1,000,000 PER YEAR FROM 2017-2019. MANAGEMENT OF MSKCC MONITORS THE USE OF GRANT FUNDS BY PARTICIPATING IN THE GOVERNANCE PROCESS OF THE RALPH LAUREN CENTER. MSKCC HAD PETITIONED NEW YORK STAE TO ALLOW RLC TO BECOME A FUNCTION OF MSKCC. FINAL APPROVAL WAS GRANTED DURING THE FIRST QUARTER OF 2019. X X true true X X X X X true true false false false false false true true true CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 1801838 0 383948 1026675 213891 3426352 348830 KERRY BESSEY SVP & CHIEF HR OFFICER 665466 0 52836 40000 35910 794212 18000 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 633699 0 44473 40000 37530 755702 21120 MICHAEL P GUTNICK EVP & CFO 996953 63014 40000 30267 1130234 21060 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 1549962 33482 974476 43844 2601764 18000 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 396324 10134 28514 31953 466925 7276 JORGE LOPEZ ESQ EVP & GENERAL COUNCEL 895245 67999 31000 42767 1037011 9000 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 717311 33763 40000 30639 821713 18000 KATHRYN MARTIN COO 1341683 33444 540000 46105 1961232 18000 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 433140 12705 30386 31010 507241 7835 RICHARD K NAUM SVP DEVELOPMENT RETIRED 7/1/18 153255 57900 18000 8191 3708 241054 18000 PATRICIA C SKARULIS SVP & CHIEF INFO OFFICER 687910 18000 40000 15934 761844 18280 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 121539 9635 131174 WENDY PERCHICK SVP STRATEGIC PLANNING & INNOV 632022 31872 40000 24521 728415 18000 MARK SVENNINGSON SVP FINANCE, CONTROLLER 639591 40174 40000 36620 756385 21060 GREGORY RASKIN VP, TECHNOLOGY DEVELOPMENT 456573 400000 10130 31000 37041 934744 9000 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 309843 195000 46404 24380 38481 614108 9000 WILLIAM MORGAN VP HR SYSTEMS & OPERATIONS 376267 450000 6365 27596 38872 899100 3629 TOMYA WATT VP TALENT ACQUISITION 336746 200000 81202 25766 33724 677438 3383 DEBRA BERNS ESQ SVP & SR RISK OFFICER 412611 100000 1614 29020 9416 552661 KENNETH MANOTTI VP DEVELOPMENT 480415 50000 40027 31000 20462 621904 SUPPLEMENTAL COMPENSATION INFORMATION SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A-INCLUDED IN FORM 990 IS SEVERANCE PAY: EDWIN TALIAFERRO, VP INTERNAL AUDIT & COMPLIANCE, OF $116,800. TERMINATED IN APRIL 2017. LINE 4B - THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. IN ADDITION, AS WELL AS AN OVERALL AUTHORIZATION AND APPROVAL FOR KEY EMPLOYEES AND OTHER MANAGEMENT INCLUDING PROFESSIONAL AND OTHER STAFF BY SETTING THE BONUS POOL IN CONJUNCTION WITH THE INPUT FROM HUMAN RESOURCES. STAFF BONUSES ARE IMPACTED BY ANNUAL MERIT REVIEW PROCESS. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false D NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 SEE PART VI false false false A 9145000 0 389043483 0 9172031 0 2651698 0 0 92720595 284499159 0 2014 false true true true B 42000000 0 80000000 0 0 0 0 0 0 0 80000000 0 true false true true C 7610507 0 110239999 0 0 0 155282 0 0 110009717 75000 0 2017 false false true true D 32625000 0 145000000 0 0 0 72861 0 0 144627139 300000 0 2018 false false true true A false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true B false false false true false 0.00000 0.00000 0.00000 false false false true C false false false true false 0.00000 0.00000 0.00000 false false false true D false false false true false 0.00000 0.00000 0.00000 false false false true A false false false true false false 0 false 0 false true B false false false true false false 0 false 0 false true C false true false false false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART I, COLUMN (F) DESCRIPTION OF PURPOSE 2012 & 2012-I SERIES BONDS - CUSIP #649906RK2: 2012 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP AN AMBULATORY FACILITY AND TO ADVANCE REFUND A PORTION OF THE 2003 SERIES BONDS ISSUED MAY 14, 2003. 2013 SERIES BONDS - CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 DASNY SERIES BONDS ISSUED 9/2/2010 2016 SERIES BONDS (DASNY) - CUSIP #000000000 2016 DASNY SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000 2016 SERIES (NJEDA) BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS - CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV LINE 2 - THE 2012 SERIES BONDS REBATE CALCULATION WERE LAST PERFORMED FEBRUARY 16, 2017. THE 2013 SERIES BONDS REBATE CALCULATIONS ARE CURRENTLY BEING PERFORMED. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2017-12-20 335567386 SEE PART VI false false false A 4000000 0 337296892 0 0 0 2262236 0 0 155915529 91432989 87686139 true false false true A false false false true false 0.00000 0.00000 0.00000 false false false true A false true false false false false 0 false 0 false true A true KING STREET CAPITAL MANAGEMENT SEE BELOW 742339 INVESTMENT MANAGEMENT FEES false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE CENTER. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2018, THE CENTER PAID KING STREET $742,339 IN MANAGEMENT FEES. MSK GAVE A REDEMPTION NOTICE AT THE END OF 2018, and PURSUANT TO standard redemption terms, WILL MAINTAIN A SMALL AND DECLINING EXPOSURE TO KING STREET THROUGHOUT 2019 AND 2020. The Institution invested in King Street prior to Ms. Nicholls joining the Board of Memorial Sloan Kettering Cancer Center. MS. NICHOLLS WAS NOT A PARTY TO THE TRANSACTION. THERE IS NO SHARING OF THE CENTER'S REVENUE. THE PURCHASES OF GOODS AND SERVICES BY THE CENTER WERE MADE IN THE ORDINARY COURSE OF BUSINESS, AT COMMERCIALLY AVAILABLE RATES normally charged to others. X 138 3114965 MARKET VALUE false true false SALE OF NON CASH CONTRIBUTIONS EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $443,965. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER. NOTE A - AFFILIATED ORGANIZATIONS MEMORIAL SLOAN-KETTERING CANCER CENTER (THE CENTER) IS AFFILIATED WITH THE FOLLOWING 501 (C) (3) ORGANIZATIONS: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (THE INSTITUTE), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (THE HOSPITAL), S.K.I. REALTY, INC., MSK INSURANCE US, INC., THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, MSKCC PROPERTIES LLC, WITH THE HOSPITAL BEING THE SOLE MEMBER, THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM (PCCTC) AND MSKCC PROTON INC. WITH THE CENTER BEING THE SOLE MEMBER. THE ORGANIZATIONS SHARE CERTAIN FACILITIES AND VARIOUS SERVICES INCLUDING ADMINISTRATIVE, PLANT AND ANCILLARY SERVICES. THE FOLLOWING IS A SUMMARY OF SUCH SERVICES: SERVICES PROVIDED TO THE CENTER BY: THE HOSPITAL $ 13,545,000 THE INSTITUTION $ 8,520,000 S.K.I. REALTY, INC. $ 2,990,000 TOTAL $ 25,055,000 SERVICES PROVIDED BY THE CENTER TO: THE HOSPITAL $522,398,000 THE INSTITUTION $144,429,000 S.K.I. REALTY, INC. $ 4,090,000 GERSTNER GRADUATE SCHOOL $ 80,000 PROSTATE CANCER CLINICAL TRIALS $ 1,148,000 TOTAL $675,586,000 MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE COLLECTIVELY REFERRED TO AS "THE ORGANIZATION". THE CENTER CARRIES ON FUNDRAISING ACTIVITIES ON ITS OWN BEHALF AND ON BEHALF OF THE AFFILIATES. CONTRIBUTIONS AND PLEDGES ARE RECORDED BASED ON THE DONOR'S INTENT IN THE RECORDS OF THE APPROPRIATE ENTITY. FOR 2018, TOTAL CONTRIBUTIONS AND PLEDGES RAISED ON BEHALF OF THE CENTER, HOSPITAL, INSTITUTE AND GRADUATE SCHOOL WERE $383,400,000. CONTRIBUTORS' INFORMATION PROVIDED IN THE ATTACHED SCHEDULE B REPRESENTS THE DONORS' TOTAL PHILANTHROPIC CONTRIBUTIONS TO THE CENTER ONLY. IF ANY DONOR LISTED ON SCHEDULE B MADE CONTRIBUTIONS TO THE HOSPITAL, INSTITUTE, OR GRADUATE SCHOOL, THOSE CONTRIBUTIONS WOULD NOT BE REFLECTED ON THE ATTACHED SCHEDULE B. FUNDRAISING EXPENSES OF $69,396,458 WERE INCURRED AND REPORTED BY THE CENTER IN PART IX, STATEMENT OF FUNCTIONAL EXPENSES. THE CENTER IS ALSO INVOLVED IN LOBBYING FOR THE HOSPITAL AND INSTITUTE, SEE SCHEDULE C. PART II-A. FORM 990, PART VI, LINE 2 FORM 990, PART VI, LINE 2 FOR THE TAX YEAR 2018, THE FOLLOWING BUSINESS RELATIONSHIPS WERE REPORTED: 1. DIRECTORS ELLEN V. FUTTER, LOUIS V. GERSTNER JR. AND PETER J. SOLOMON 2. DIRECTORS NORMAN C. SELBY, STANLEY F. DRUCKENMILLER, ALEXANDER T. ROBERTSON AND OFFICER ERIC M. COTTINGTON PHD. 3. DIRECTORS ANTHONY B. EVNIN AND NORMAN C. SELBY 4. DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE FORM 990, PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VICE PRESIDENT OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IN ADDITION, FORM 990 IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PREAPPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE (COIAC) MEETINGS, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4. DOCUMENTATION OF THE OUTCOMES OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. 5. THE CENTERS BOARD HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY TRADED COMPANIES. THE ORGANIZATION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE COMPANIES' BUSINESS ON TERMS AND CONDITIONS WHICH ARE NOT INFLUENCED BY MEMBERS OF OUR BOARD OF MANAGERS AND WHICH WE ASSUME ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. THE ORGANIZATION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. TRANSACTIONS IDENTIFIED THROUGH OUR CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS ARE CONSUMMATED ON AN ARM'S LENGTH BASIS BETWEEN MANAGEMENT OF THE INSTITUTION AND THE COMPANY. ORGANIZATION's "Policy on Conflicts of Interests for Directors and Key Employees" applies to any Board of Managers member, principal officer, or member of a committee with Board-delegated powers. Individuals covered by this policy have a duty to disclose Financial Interests, as defined by the Policy, annually and as they arise. In the event a covered individual is involved in a Board or committee action (such as approval of a transaction or arrangement) and the individual has a Financial Interest related to the matter before the Board, the individual must disclose the Financial Interest and all material facts to the Board or committee. The individual must leave the meeting while the determination of a conflict of interest is discussed and voted upon, and the remaining disinterested Board or committee members are responsible to decide if a conflict exists. If a determination is made that a conflict exists, the involved individual may make a presentation to the Board or committee, but s/he must leave the meeting during the discussion of and the vote on the transaction or arrangement. The Board or committee is required to determine whether the organization can obtain a more advantageous transaction or arrangement with reasonable efforts from an unconflicted person or entity. As appropriate, the chairperson of the Board or Committee is responsible to appoint a disinterested person or committee to investigate alternatives to the proposed transaction or arrangement. FORM 990, PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2017. THIS REVIEWS SETS THE COMPENSATION FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS' GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. FORM 990, PART VI, LINE 19 FORM 990, PART VI, LINE 19 THE AUDITED FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE ORGANIZATION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND THE APPLICABLE 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS FOR SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. FORM 990, PART XI, LINE 9 CHANGE IN POSTRETIREMENT EXPENSE $74,072,000 OTHER NON-OPERATING EXPENSES ($16,196,000) NET-OTHER CHANGES IN NET ASSETS $57,876,000 FORM 990, PART XII, LINE 2 THE FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AUDITED BY AN INDEPENDENT ACCOUNTING FIRM ON A COMBINED BASIS. THE COMBINED STATEMENTS INCLUDE THE ACCOUNTS OF THE FOLLOWING TAX EXEMPT, SECTION 501 (C) (3), INCORPORATED AFFILIATES: MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (EIN 13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (EIN 13-1624182), S.K.I. REALTY, INC. (EIN 13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (EIN 20-2212588), AND MSK INSURANCE US, INC.(MVI) EIN 83-0363317. INCLUDED IN THE GROUP EXEMPTION IS MSKCC PROPERTIES LLC (EIN 35-2464610) WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, AND MSKCC PROTON, INC. (EIN 35-2397819). THE CENTER'S FINANCIAL STATEMENTS ARE NOT AUDITED INDEPENDENT OF THE COMBINED. REFER TO SCHEDULE D FOR A RECONCILIATION OF THE 990 TO THE CENTER'S FINANCIAL STATEMENTS. STRATEGIC PLANNING AND COMMUNITY BENEFITS STRATEGIC PLANNING MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES AS REPORTED ON A COMBINED BASIS WITH A SEPARATE GROUP 990 FILING UNDER EIN # 91-2154236. MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE INTERTWINED WITH COMMUNITY BENEFITS AND FINANCIAL ASSISTANCE ACTIVITIES AS OUTLINED BELOW. MSKCC'S STRATEGIC PLANNING PROCESS INCLUDES DEVELOPING PROGRAMS IN RESPONSE TO CANCER MORBIDITY AND MORTALITY DATA, DEMOGRAPHIC DATA, AND COMMUNITY INPUT IN ACCORDANCE WITH ITS IRS "COMMUNITY HEALTH NEEDS ASSESSMENTS" REQUIREMENTS. THESE FINDINGS ARE USED IN DESIGNING AN IMPLEMENTATION STRATEGY TO PLAN INITIATIVES AND PROGRAMS AIMED AT IMPROVING OUR COMMUNITIES' ACCESS TO CANCER INFORMATION. IN ADDITION, THE ORGANIZATION'S STRATEGIC EFFORTS ARE FOCUSED ON REDUCING THE CRITICAL ISSUE OF CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCC'S INPATIENT HOSPITAL IS LOCATED IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE SAME LOCATIONS AS OUR FACILITIES. A TOTAL OF 186,563 PATIENTS WERE SEEN AT MSKCC'S FACILITIES IN 2018, INCLUDING 167,527 PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 17,286 PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 1,750 PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 24,243 ADMISSIONS TO OUR HOSPITAL WITH 129,207 RELATED HOSPITAL VISITS AND 647,339 OUTPATIENT VISITS AT THE COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. SINCE 1987, MSKCC HAS HAD A FINANCIAL ASSISTANCE PROGRAM (FAP) IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES (FPG) MAY BE ELIGIBLE FOR THE FAP. FURTHERMORE, WE MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES - INCLUDING MEDICARE AND MEDICAID - TO HELP THE PATIENTS GAIN ACCESS TO SERVICES. THOSE WHO DON'T QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES MAY OBTAIN HELP THROUGH FAP IF THEY ARE ELIGIBLE. THE PREMISE OF THE PROGRAM IS THAT ALL PATIENTS ARE EXPECTED TO CONTRIBUTE TO THEIR CARE BASED ON THEIR FINANCIAL ABILITY. THE FINANCIAL ASSISTANCE PROGRAM EMPLOYS SEVERAL STRATEGIES TO INCREASE PATIENTS' AWARENESS OF THE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE, INCLUDING GOVERNMENTAL PROGRAMS AND THE FAP. MSKCC PERSONNEL SENDS A COPY OF THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED ON EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT AND ON EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS SHE/HE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR ASSISTANCE AND RETRO ACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE. INFORMATION ABOUT THE FAP IS ALSO AVAILABLE ON THE INSTITUTION'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE, DISPOSABLE INCOME." MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINES USED. FAMILY SIZE ALLOWED INCOME RESOURCE LEVELS 1 $60,700 $37,875 2 $82,300 $55,500 3 $103,900 $62,535 4 $125,500 $70,688 5 $147,100 $78,848 6 $168,700 $87,000 STRATEGIC PLANNING AND COMMUNITY BENEFITS - CONTINUED MSKCC ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES IT SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCES WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY,THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. MSKCC CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) IN THE FALL OF 2016 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH CONCERNS FACING RESIDENTS IN OUR CATCHMENT AREA. THE ASSESSMENT INCLUDED AN ANALYSIS OF CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY. WE ALSO REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS AND THE GENERAL PUBLIC. TO ENGAGE THE BROAD COMMUNITY IN THE ASSESSMENT, WE HELD A SERIES OF COMMUNITY FORUMS IN HARLEM, BROOKLYN, AND MANHATTAN, AS WELL AS WEBINARS WITH FURTHER REACHES TO OUR CATCHMENT AREAS. THESE FORUMS WERE CONDUCTED TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS INCLUDING PRIVATE, NON-PROFIT, PUBLIC AND GOVERNMENT AGENCIES THAT WORK TO MEET COMMUNITY NEEDS WITH SERVICES AND RESOURCES THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 22 COMMUNITY-BASED ORGANIZATIONS PARTICIPATED IN THE FORUMS AND SERVE A DIVERSE RANGE OF CLIENTS. SERVICES PROVIDED BY THESE ORGANIZATIONS INCLUDE CANCER SUPPORT SERVICES, DOMESTIC VIOLENCE SUPPORT, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. SUMMARY FINDINGS OF MSKCC 'S CHNA WERE SENT TO COMMUNITY BASED ORGANIZATIONS WITH WHOM WE WORK AND WERE ALSO INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN (CSP). THE CSP IS DISTRIBUTED TO LOCAL ELECTED OFFICIALS, ORGANIZATIONS, AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. THE CHNA WAS ALSO PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTERS WHICH ARE DISTRIBUTED TO APPROXIMATELY 50,000 RESIDENTS NEAR OUR TREATMENT FACILITIES. EDUCATION AND TRAINING ARE KEY COMPONENTS OF MSKCC'S MISSION, AND IMPORTANT EXAMPLES OF HOW WE MAKE CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSKCC ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSKCC SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS MSKCC STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. MSKCC'S OFFICE OF DIVERSITY PROGRAMS IN CLINICAL CARE, RESEARCH, AND TRAINING (ODP) PROVIDES FUNDING TO ENCOURAGE INTEREST IN PURSUING CAREERS IN THE FIELD OF ONCOLOGY FOR MEMBERS OF MINORITY GROUPS WHO ARE UNDERREPRESENTED IN MEDICINE AND WISH TO PARTICIPATE IN THE NATIONAL CANCER INSTITUTE'S MEDICAL STUDENTS SUMMER FELLOWSHIP PROGRAM. THE ODP ALSO COORDINATES A SIX-WEEK SUMMER EXPOSURE PROGRAM TO EXPOSE UNDERREPRESENTED MINORITY HIGH SCHOOL STUDENTS TO CAREERS IN MEDICINE AND RESEARCH. MSKCC UTILIZED $244.8M DURING 2018 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE SEE AS VITAL GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. MSKCC FOCUSES ON MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AS WELL AS FOR PATIENTS AS A WHOLE WITH ANY PARTICULAR TYPE OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS -- CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2018, MEMORIAL SLOAN KETTERING CANCER CENTER EXPENDED $529.5M IN SUPPORT OF ITS RESEARCH MISSION. PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 9974000 2251000 MSKCC RALPH LAUREN CTR FOR CANCER & PRVENTION 1919 MADISON AVENUE NEW YORK NY 10036 020597827 CANCER CARE NY 501( c)3 10 MSKCC true MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501 (C )3 10 MSKCC true MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM related 282411 0 false 0 true 0.01000 MEM PATHOLOGY GROUP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 498004 0 false 0 true 0.01000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 595317 0 false 0 true 0.01000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 101906 0 false 0 true 0.01000 MEM NEUROLOGY GROUP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 113368 0 false 0 true 0.01000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 46804 0 false 0 true 0.01000 MSKCC PHYS PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM related -18 0 false 0 true 0.01000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM related 62415 0 false 0 true 0.01000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 28198 0 false 0 true 0.01000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 1581744 0 false 0 true 0.01000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 55924 0 false 0 true 0.01000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 10609 0 false 0 true 0.01000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 155440 0 false 0 true 0.01000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 142281 0 false 0 true 0.01000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 73309 0 false 0 true 0.01000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 3122 0 false 0 true 0.01000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 59404 0 false 0 true 0.01000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY mem RELATED 81165 0 false 0 true 0.01000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 132125 0 false 0 true 0.01000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 10 0 false 0 true 0.01000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 22419 0 false 0 true 0.01000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 426531 0 false 0 true 0.01000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 69112 0 false 0 true 0.01000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 35913 0 false 0 true 0.01000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 79218 0 false 0 true 0.01000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 204521 0 false 0 true 0.01000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 41436 0 false 0 true 0.01000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 58494 0 false 0 true 0.01000 MSKCC RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 813142 0 false 0 true 0.01000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 85334 0 false 0 true 0.01000 MSK HARRISON 1275 YORK AVE NY NY 10065 300831483 HEALTH CARE NY MEM RELATED 170865 0 false 0 true 0.01000 MSK BERGEN 1275 YORK AVE NY NY 10065 611791803 HEALTH CARE NY MEM RELATED 17183 0 false 0 true 0.01000 MSK MONMOUTH 1275 YORK AVE NY NY 10065 300937486 HEALTH CARE NY MEM RELATED 113276 0 false 0 true 0.01000 PANAKEIA ENERGY 10000 MEMORIAL DR HOUSTON TX 77024 800891961 INVESTMENT DE MSK EXCLUDED UNDER 512 1252884 17746632 false -1333710 true 0.99223 BTS LIQUIDATING LLC 1430 BROADWAY NY NY 10018 262602952 INVESTMENT NY MSK EXCLUDED UNDER 512 -66554970 1286339 false 0 true 0.70000 CHARITABLE REMAINDER TRUSTS 239 N/A TWO SIGMA US ALL CAP 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY1-9007 INVESTMENT CJ MSK C 13146621 105994044 0.10000 true false true false false false false false false false true true true false false false true false false MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 522398000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH L 147870000 COST SKI REALTY INC L 4090000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL L 80000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE M 13545000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH M 8250000 COST SKI REALTY INC K 2990000 cost RALPH LAUREN CTR FOR CANCER & PREVENTION Q 3967000 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1000000 cost